Allergy Therapeutics plc

Direct answer

Allergy Therapeutics plc is publicly traded on LSE under the ticker AGY.L.

Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features...

Can you invest in Allergy Therapeutics plc?

Yes. Allergy Therapeutics plc is publicly traded on LSE under the ticker AGY.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Allergy Therapeutics plc

Detailed equity research is provided by MarketSnap.